Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

We have observed 14 EP applications Scott Goodall has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12712748

METHOD FOR PREPARING MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE CONJUGATES

IPC classification:
A61K 47/48, A61K 39/00, C07K 9/00
Applicant:
Institut Pasteur
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14162956

Cysteine protease inhibitors

IPC classification:
A61K 31/16, C07D 233/58, C07C 237/14, A61P 37/00, A61P 11/00
Agent:
Scott Goodall, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13716919

USE OF NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY

IPC classification:
A61K 38/18, A61K 38/17, A61K 38/16, A61P 25/02
Agent:
Scott Goodall, Sagittarius IP
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Status:
The patent has been granted
EP13830653

PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF

IPC classification:
A61K 31/5377, A61K 31/444, A61K 31/4439, A61K 31/404, A61K 31/4035, C07D 417/14, C07D 409/14, C07D 409/10, C07D 401/10, A61P 37/06, A61P 3/10
Agent:
Scott Goodall, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14712964

THERAPEUTIC DOSING OF A NEUREGULIN OR A FRAGMENT THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE

IPC classification:
A61P 9/00, A61K 38/18
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14750516

FORM 2 CRYSTALLINE POLYMORPH OF A SALT OF N-[1-6-(ETHYNYL-3-OXO-HEXAHYDRO-FURO[3,2-B]PYRROLE-4-CARBONYL)-3-METHYL-BUTYL]-4-[5-FLUORO-2-(4-METHYL-PIPERAZINYL)THIAZOL-4-YL]-BENZAMIDE USEFUL AS CYSTEINE PROTEASE INHIBITOR

IPC classification:
A61P 19/00, A61K 31/496, C07D 491/048
Agent:
Scott Goodall, Sagittarius IP
Status:
The patent has been granted
EP14789434

HCV POLYMERASE INHIBITORS

IPC classification:
A61P 31/14, C07H 19/16, C07H 19/06
Agent:
Scott Goodall, Sagittarius IP
Status:
The patent has been granted
EP14802498

HCV POLYMERASE INHIBITORS

IPC classification:
C07H 19/10, A61P 31/14, A61K 31/7072, A61K 31/7068, C07H 19/06
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11805571

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

IPC classification:
A61P 43/00, A61P 27/16, A61P 25/18, A61P 25/08, A61K 31/506, A61K 31/4439, A61K 31/4178, C07D 413/14, C07D 413/12, C07D 405/12
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11794778

MYCOBACTERIUM ANTIGENIC COMPOSITION

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15756888

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

IPC classification:
A61P 35/00, A61K 31/506, C07F 9/24, C07D 405/04
Agent:
Per Hampus Rystedt, Zacco
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15763562

METHODS FOR THE PREPARATION OF DIASTEREOMERICALLY PURE PHOSPHORAMIDATE PRODRUGS

IPC classification:
C07H 19/20, C07H 19/10, C07H 1/04
Agent:
Zacco
Agent:
Scott Goodall, Sagittarius IP
Status:
Request for examination was made
EP17176973

HCV POLYMERASE INHIBITORS

IPC classification:
A61P 31/14, A61K 31/7072, C07H 19/173, C07H 19/073, C07H 19/16, C07H 19/10
Agent:
Scott Goodall, Sagittarius IP
Status:
Request for examination was made
EP16759216

NUCLEOTIDE PHOSPHORAMIDATE FORMULATION

IPC classification:
C07H 19/10, A61P 31/14, A61K 31/7072
Agent:
Zacco
Agent:
Scott Goodall, Sagittarius IP
Status:
Request for examination was made

Please Sign in to use this feature